VORSCHAU
Frühere Meldungen
PRESSETERMINE
AKTUELLES PRESSEFOTO
IR Nachrichten
19.12.2024 18:34
Empire Brand Building AG
19.12.2024 16:25
Rosenbauer International AG
19.12.2024 16:05
medondo holding ag
EUROPA NACHRICHTEN
ADHOC
Do, 19.12.2024 13:00
pta20241219021
Public disclosure of inside information according to article 17 MAR
Darwin AG: Darwin AG acquires all shares in MEDICOPHARM AGMunich, 19/12/2024 (pta021/19.12.2024/13:00) - Darwin AG (ISIN DE000A3C35W0) has acquired all shares in MEDICOPHARM AG Arzneimittel und Medikal Produkte (hereinafter "Medicopharm"), based in Nußdorf am Inn, with a purchase agreement dated today. Medicopharm is active in the manufacture and distribution of pharmaceuticals and thus complements Darwin AG's existing portfolio in this sector. According to the management board of Darwin AG, the acquisition will have a significant impact on the group's earnings situation. The parties have agreed not to disclose the economic details of the transaction. Background The "Darwin Group" (i.e. Darwin AG including its subsidiaries), headquartered in Munich (Germany), is a European biotechnology company, particularly in the field of human genetics. The genetic analysis carried out in our own laboratory are used in diagnostics, therapy and prevention of diseases as well as in the production of individually designed nutritional supplements and cosmetics. Darwin also acts as a partner for doctors, therapists, pharmacists, nutritionists or fitness trainers and, by analyzing the respective genetic predisposition of the patient or customer, helps to ensure the best possible treatment or care for their needs. Darwin also invests in innovative companies in the biotech, healthcare and life sciences sectors.
(Ende)
PRESSETEXT.TV
PORR rechnet mit anhaltender Baukonjunktur 30.10.2024 ETARGET
FOCUSTHEMA
SPECIALS
Werbung
middleAdvertising
|